Waystar recognized as the leading healthcare software platform with top marks for client satisfaction
LEHI, Utah and LOUISVILLE, Ky., Feb. 5, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced its top ranking in multiple 2025 Best in KLAS categories: Claims Management & Clearinghouse and Patient Access. Based on independent client feedback, these recognitions underscore the value healthcare providers gain from Waystar's AI-powered software platform, fueled by continuous innovation and a steadfast focus on client satisfaction, empowering providers to tackle the industry's most pressing challenges.
Providers cite the need for improved client service as the primary driver for switching revenue cycle management vendors, according to a recent third-party survey. The latest Best in KLAS results highlight Waystar's commitment to client support excellence, with number-one rankings in claims management & clearinghouse and patient access solutions. These recognitions underscore Waystar's status as a top software leader in revenue cycle management, marking over a dozen consecutive years of being named Best in KLAS.
"We are honored to receive this feedback from healthcare providers regarding our innovation and unwavering commitment to client support," said Matt Hawkins, Chief Executive Officer of Waystar. "Waystar will continue to build and deliver advanced, end-to-end revenue cycle solutions that help our clients achieve their operational goals while enhancing transparency and fairness for both providers and their patients."
Providers increasingly turn to Waystar's software to navigate operational complexities and position themselves for future success. Waystar's platform optimizes revenue cycle workflows by integrating front-end patient access with back-end claims management to achieve operational efficiency and a meaningful ROI. Its powerful automation capabilities enhance denial prevention through eligibility verification and coverage detection, accelerating reimbursements. Powered by Waystar AltitudeAI™, a comprehensive set of AI capabilities for providers, the platform continuously adapts to changing payer policies and claim trends, delivering predictive insights that improve financial performance, ultimately enabling providers to achieve elevated productivity and precision in healthcare payments.
In 2024, Waystar's claims and clearinghouse solutions played a crucial role in stabilizing the healthcare industry after a cyber incident that disrupted claims processing nationwide. In response, Waystar launched the Accelerated Implementation Program, quickly onboarding over 30,000 providers to its clearinghouse, restoring cash flow and ensuring continuity of care. Many of these providers have committed long-term to Waystar, expanding their adoption of additional solutions on the platform and becoming more active in their client community.
Waystar's recognition by KLAS adds to a series of recent prestigious third-party awards, including Forbes' Most Trusted Companies in America, Fortune's Best Workplaces in Health Care, the Healthcare Payments Innovation Award from MedTech Breakthrough, and multiple Gold Stevie® Awards for the company's cloud-based software platform and leadership in AI.
About WaystarWaystar's mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves approximately 30,000 clients, representing over 1 million distinct providers, including 16 of 20 institutions on the U.S. News Best Hospitals Honor Roll. Waystar's enterprise-grade platform annually processes over 5 billion healthcare payment transactions, including over $1.2 trillion in annual gross claims and spanning approximately 50% of U.S. patients. Waystar strives to transform healthcare payments so providers can focus on what matters most: their patients and communities. Discover the way forward at waystar.com.
Media ContactKristin Leekristin.lee@waystar.com
Investor ContactSandy Draperinvestors@waystar.com502-238-9511
View original content to download multimedia:https://www.prnewswire.com/news-releases/waystar-recognized-as-the-leading-healthcare-software-platform-with-top-marks-for-client-satisfaction-302368229.html
SOURCE Waystar
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
Why monday.com (MNDY) Stock Is Trading Lower Today
What Happened? Shares of work management platform (NASDAQ:MNDY) fell 3.9% in the morning session after Bank of America downgraded the stock from "Buy" to "Neutral". The bank also lowered its price target on the stock to $205 from $240. The downgrade reflects growing concerns over the company's SEO-driven web traffic, which has reportedly seen a notable decline. According to the BofA Securities analyst, there is also potential for future revenue pressure on the company as search engines continue to integrate artificial intelligence. This shift in technology could impact how customers discover and interact with platform. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Access our full analysis report here, it's free. What Is The Market Telling Us shares are very volatile and have had 29 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. The previous big move we wrote about was 8 days ago when the stock gained 3.7% on the news that the SaaS sector continued to rally as favorable inflation data bolstered hopes for a Federal Reserve interest rate cut. This optimism was largely driven by a benign July Consumer Price Index (CPI) report, which solidified investor expectations for a Federal Reserve interest rate cut. Following the release of the inflation data, which showed a year-over-year increase of 2.7%, the probability of a rate cut in September surged to over 96%. Lower interest rates are typically beneficial for growth-oriented technology stocks, as they can reduce borrowing costs and increase the present value of future earnings. Adding to the positive sentiment was a 90-day delay in the imposition of higher tariffs on Chinese goods, which reduced trade-related uncertainty for the technology sector. is down 26% since the beginning of the year, and at $170.98 per share, it is trading 47.9% below its 52-week high of $327.92 from February 2025. Investors who bought $1,000 worth of shares at the IPO in June 2021 would now be looking at an investment worth $955.89. Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
18 minutes ago
- Yahoo
Accuray (ARAY) Beats Q4 Revenue Estimates, BTIG Maintains Buy Rating
Accuray Incorporated (NASDAQ:ARAY) ranks among the . After Accuray Incorporated (NASDAQ:ARAY) reported fiscal fourth-quarter results and fiscal 2026 outlook, BTIG maintained its Buy rating on the radiation therapy company and increased its price target from $4 to $5 on August 14. Photo by Accuray on Unsplash Accuray's fiscal fourth-quarter revenue of $127.5 million exceeded consensus projections of $123.8 million, despite a 5% year-over-year decline. Product revenue of $70.7 million, which was over $4 million higher than the forecast, was the main driver of the sales beat, while services revenue of $56.8 million remained as expected. According to BTIG, Accuray Incorporated (NASDAQ:ARAY) overcame several obstacles during the quarter, such as the temporary suspension of shipments to China and the disruptions caused by Middle East hostilities in the EIMEA region. The firm thinks management has a realistic outlook for fiscal 2026, with room for improvement if macroeconomic headwinds and the tariff situation with China improve. Accuray Incorporated (NASDAQ:ARAY) that is involved in developing cutting-edge cancer and neuro-radiosurgery solutions. The CyberKnife technology, which treats primary and metastatic malignancies outside the brain, is the company's most well-known robotic stereotactic radiosurgery and stereotactic body radiation therapy technology. While we acknowledge the potential of ARAY to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ARAY and that has 100x upside potential, check out our report about this cheapest AI stock. READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
18 minutes ago
- Yahoo
Richtech Robotics (RR) Expands in China With $4 Million Sales Agreement
Richtech Robotics Inc. (NASDAQ:RR) ranks among the . Through its Chinese joint venture, Richtech Robotics Inc. (NASDAQ:RR) reported at the end of June that it had reached a sales agreement with Beijing Tongchuang Technology Development Co., Ltd. worth more than $4 million. possessed-photography-jIBMSMs4_kA-unsplash The contract covers the acquisition, maintenance, and software licensing of products from Richtech's ADAM, Scorpion, and Titan product lines. With analysts forecasting 33% rise in revenues for the fiscal year, the purchase is anticipated to boost the company's fourth-quarter revenue and create recurring revenue moving forward. According to a press release from the company, the new collaboration increases Richtech Robotics' footprint in China and could lead to new prospects throughout the Asian market. Richtech Robotics Inc. (NASDAQ:RR) specializes in interactive robotic solutions for the service sector, with additional applications in the healthcare and hotel industries. While we acknowledge the potential of RR to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than RR and that has 100x upside potential, check out our report about this cheapest AI stock. READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
